NCT05282459 2026-04-17Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 MutationStanford UniversityPhase 1/2 Completed17 enrolled 12 charts
NCT00534469 2025-12-02Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep RCity of Hope Medical CenterPhase 2 Completed60 enrolled 9 charts
NCT01822015 2025-04-29Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaThomas Jefferson UniversityPhase EARLY_PHASE1 Completed55 enrolled